Krka Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Krka d. d.
Access all reports
Krka, d. d., Novo mesto is a Slovenia-based international generic pharmaceutical company. The company focuses on the development, production, marketing, and sales of pharmaceutical products for human health, including prescription pharmaceuticals, self-medication products, and cosmetics. Additionally, Krka extends its product range to animal health products. With a presence in more than 70 countries, Krka has established production and distribution centers in key markets such as Russia, Poland, Croatia, and Germany, supporting its global distribution network. The company's commitment to quality and innovation has been instrumental in its expansion and ability to meet diverse health needs worldwide. The company is headquartered in Novo Mesto, Slovenia, and its shares are listed on the Warsaw Stock Exchange.
Key slides for Krka d. d.
Q4 2023
Krka d. d.
H1 2023
Krka d. d.
Latest articles
Companies That Had Their IPO in 2019: Bull Market and Tech Dominance
Discussing the stock and IPO market in 2019, and the factors that led to the overall bullish performance of stocks during the year.
3 May 2024
Microsoft's Journey to Becoming the World's Most Valuable Company
Explore Microsoft's rise from a garage startup to the world's most valuable company, highlighting Bill Gates' role in shaping the digital revolution.
3 May 2024
Bill Gates: The Man Who Put a Computer in Every Home
Explore the life of Bill Gates, from co-founding Microsoft to global philanthropy, and his lasting impact on the world.
2 May 2024
Ticker symbol
Country
SI